National	NorthEast	NorthCentral	NorthWest	SouthEast	SouthCentral	SouthWest
Enterococcus faecalis	Enterococcus faecium	Staphylococcus aureus	Streptococcus pneumoniae	Escherichia coli	Haemophilus influenzae	Proteus Mirabilis	Pseudomonas aeruginosa

Choose chart to view: amoxicillin/clavulanate through ceftazidime | ceftriaxone through tobramycin | amikacin through ticarcillin/clavulanate

Proteus mirabilis (SOUTHCENTRAL Data)
	2004	2005	2006	2007	2008	2009	2010
amoxicillin/clavulanate	100% n=31
ampicillin	75.7% n=280	97.5% n=40
ampicillin/sulbactam	78.6% n=280	95% n=40
cefazolin	82.9% n=280	92.5% n=40
cefotetan	100% n=55
cefuroxime	92.7% n=150
cefotaxime	100% n=86
ceftazidime	99.5% n=193	100% n=40
ceftriaxone	99.1% n=225	100% n=40
cefepime	100% n=280	97.5% n=40
ciprofloxacin	64.6% n=280	47.5% n=40
levofloxacin	71.1% n=280	47.5% n=40
gatifloxacin	72.2% n=54
TMP/SMX	74.6% n=138	65% n=40
gentamicin	86.4% n=280	92.5% n=40
tobramycin	87.1% n=280	90% n=40
amikacin	100% n=31
aztreonam	93.5% n=31
imipenem	93.9% n=280	100% n=40
piperacillin	70.5% n=173
pip/taz	98.2% n=278	100% n=40
ticarcillin/clavulanate	98.8% n=86
Totals	85.9% n=4051	86.5% n=520

This data is accurate as of: 11/22/2016 11:55:24 AM

Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: amoxicillin/clavulanate, cefotetan, cefotaxime, gatifloxacin, amikacin, aztreonam, ticarcillin/clavulanate, ampicillin, ampicillin/sulbactam, cefazolin, ceftazidime, ceftriaxone, cefepime, ciprofloxacin, levofloxacin, TMP/SMX, gentamicin, tobramycin, imipenem, pip/taz.